Literature DB >> 7831437

Serotonin, dopamine and their interactions in schizophrenia.

R S Kahn, M Davidson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 7831437     DOI： 10.1007/bf02245002

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  17 in total

1.  Thymosthenic agents, a novel approach in the treatment of schizophrenia.

Authors:  Y G Gelders
Journal:  Br J Psychiatry Suppl       Date:  1989-07

Review 2.  Dopamine in schizophrenia: a review and reconceptualization.

Authors:  K L Davis; R S Kahn; G Ko; M Davidson
Journal:  Am J Psychiatry       Date:  1991-11       Impact factor: 18.112

3.  Neurotransmitter receptors in frontal cortex of schizophrenics.

Authors:  J P Bennett; S J Enna; D B Bylund; J C Gillin; R J Wyatt; S H Snyder
Journal:  Arch Gen Psychiatry       Date:  1979-08

4.  Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine.

Authors:  J Kane; G Honigfeld; J Singer; H Meltzer
Journal:  Arch Gen Psychiatry       Date:  1988-09

Review 5.  The role of serotonin in schizophrenia.

Authors:  A Bleich; S L Brown; R Kahn; H M van Praag
Journal:  Schizophr Bull       Date:  1988       Impact factor: 9.306

6.  Effect of neuroleptic medication on cerebrospinal fluid monoamine metabolite concentrations in schizophrenia. Serotonin-dopamine interactions as a target for treatment.

Authors:  R S Kahn; M Davidson; P Knott; R G Stern; S Apter; K L Davis
Journal:  Arch Gen Psychiatry       Date:  1993-08

7.  Serotonin function in schizophrenia: effects of meta-chlorophenylpiperazine in schizophrenic patients and healthy subjects.

Authors:  R S Kahn; L J Siever; S Gabriel; F Amin; R G Stern; K DuMont; S Apter; M Davidson
Journal:  Psychiatry Res       Date:  1992-07       Impact factor: 3.222

8.  Clinical and biologic response to clozapine in patients with schizophrenia. Crossover comparison with fluphenazine.

Authors:  D Pickar; R R Owen; R E Litman; E Konicki; R Gutierrez; M H Rapaport
Journal:  Arch Gen Psychiatry       Date:  1992-05

9.  Neuroendocrine responses in chronic schizophrenia. Evidence for serotonergic dysfunction.

Authors:  B Lerer; A Ran; M Blacker; H Silver; M P Weller; D Drummer; B Ebstein; A Calev
Journal:  Schizophr Res       Date:  1988 Nov-Dec       Impact factor: 4.939

Review 10.  Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia.

Authors:  H Y Meltzer
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530
View more
  5 in total

Review 1.  Neurotensin agonists: potential in the treatment of schizophrenia.

Authors:  Mona Boules; Amanda Shaw; Paul Fredrickson; Elliott Richelson
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

2.  Effect of D-serine on the serotonin receptors of human platelets.

Authors:  Kaneez Fatima Shad
Journal:  Exp Brain Res       Date:  2006-05-06       Impact factor: 1.972

3.  Activation, internalization, and recycling of the serotonin 2A receptor by dopamine.

Authors:  Samarjit Bhattacharyya; Ishier Raote; Aditi Bhattacharya; Ricardo Miledi; Mitradas M Panicker
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-27       Impact factor: 11.205

Review 4.  Neuroleptic dysphoria: towards a new synthesis.

Authors:  L Voruganti; A G Awad
Journal:  Psychopharmacology (Berl)       Date:  2003-11-27       Impact factor: 4.530

5.  Mean diffusivity of globus pallidus associated with verbal creativity measured by divergent thinking and creativity-related temperaments in young healthy adults.

Authors:  Hikaru Takeuchi; Yasuyuki Taki; Atsushi Sekiguchi; Hiroshi Hashizume; Rui Nouchi; Yuko Sassa; Yuka Kotozaki; Carlos Makoto Miyauchi; Ryoichi Yokoyama; Kunio Iizuka; Seishu Nakagawa; Tomomi Nagase; Keiko Kunitoki; Ryuta Kawashima
Journal:  Hum Brain Mapp       Date:  2015-01-27       Impact factor: 5.038
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.